Palliative care has the potential to play significant role in better quality of dying and death for non-cancer patients. The purpose of this review is to determine the definition of quality of dying and death for non-cancer patients. MEDLINE (1990MEDLINE ( -2015 and Google Scholar (1999Scholar ( -2015 were searched using keyword terms 'quality of dying or death', 'good or bad death'. In the 13 definitions of QODD, the most common terms are related to patient's decision-making. The most common second terms are related to medical and social support. Final terms are related to psychological support. In order for the social and psychological aspects of death awareness and acceptance to take place, the dying person's suffering should be reduced and they must be relieved of pain. Furthermore, it is rapidly increased percentages of non-cancer patients among those utilising specialist palliative care services in the countries at the top of the quality of death ranking such as United Kingdom and the United States. Unlike cancer disease, non-cancer diseases need to longitudinal supportive system. Palliative care will be effective intervention to manage symptoms of non-cancer patients and treat intercurrent medical condition is appropriate.
Ⅰ. Introduction
The life expectancy has increased rapidly since the onset of industrialization and modernization. The physical health and mental health have also spotlighted with the frequent uses of the terms of the quality of life (QOL) and well-being (Kohara, Han, Tanaka, et al., 2013) . In contrast, death may still be so far from daily experience that its possibility may be denied or come as a surprise. Medicine is also charged with promoting the view that death is a failure, rather than something normal that may be put off but that will happen eventually (WHO, 2004) .
A taxonomy of QOL for dying persons defined quality of life for patients and for loved ones at the end of life (Stewart, Teno, Patrick, et al., 1999) . This framework also included a separate domain labeled the quality of dying, defined as a personal evaluation of the dying experience as a whole, including a subjective evaluation of concepts according to expectations and values (Patrick, Engelberg & Curtis, 2001 ). Therefore, the quality of dying and death (QODD) pertains to the period leading up to death, although there is ambiguity about when the transition to the dying phase occurs (WHO, 2004) . QODD closely related to field of palliative care. Palliative care tends to focus on symptom management and relief, but that patients primarily value communication at the end of life (Trotta, 2007) .
Palliative care has been historically developed with the focus on cancer. However, recent rapid global ageing and changes in disease prevalence, which are particularly evident in developed countries, have brought renewed attention to palliative care for chronic non-cancer diseases (Oishi & Murtagh, 2014 ). Functional status declined at different time point in Cancer and non-cancer diseases. Most patients with malignancies status usually declined quite rapidly in functional status when they get closer to death.
However, non-cancer diseases like end stage heart disease, end stage lung disease, and dementia the patient's functional status gradually declined compared to terminal cancer patients. Non-cancer diseases have to supported services at home, like Meals on Wheels and home health aides, then institutional long-term care facilities are central to good care for these patients (Lynn & Adamson, 2003) . Palliative care services may change over time in patients with cancer and non-cancer diseases, and also different set of goals in 
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Therefore, the purpose of this paper is to review definitions of the QODD and to summarize the definition of QODD for patients with non-cancer diseases.
Ⅱ. Methods
Literature sampling
We searched published studies that reported on the development, validation of measures the QODD. We also searched reviewed reports on palliative care in patients with non-cancer diseases.
Papers were obtained from searches of MEDLINE (1999 MEDLINE ( -2015 and Google Scholar (1999-2015) using the keyword search terms 'quality of dying', 'quality of death', 'good death' and 'bad death'. In the second part, the keywords were 'palliative care' 'end-of-life care', 'review' and 'non-cancer'. All databases were restricted to those published in English between January 1990 and September 2015.
20 articles identified for study selection. Exclusion of 7 studies that did not explained about definition of QODD. A total of 13 papers met the inclusion criteria.
Inclusion criteria
Studies were included in this review if they met the following criteria: (1) review or clinical report that measured QODD in patients with non-cancer disease, (2) also indicated about definition of QODD.
Exclusion criteria
Studies were excluded if they were (1) unpublished studies, abstracts or dissertations, (2) studies without measured QODD, (3) not written in English language, letters, editorials, and case reports. The quality of dying and death in subjectively determined with numerous factors that influence its judgement, including culture, type and stage of disease, and social and professional role in the dying experience. Quality of dying and death is broader in scope than either quality of life at the end of life or quality of care at the end of life, although there is overlap among these constructs. The notion of quality of death implies a health outcome minimizing pain and suffering, maximizing the autonomy of the patient's wishes, and respecting the sanctity of life. A good death is one that is pain free, peaceful, dignified, at a place of choosing with relatives present and without futile heroic interventions. A good death is one in which a patient's suffering is reduced as much as possible and death is accompanied by dignity; includes awareness, acceptance, arranging will, and appropriate timing of death.
Carr, 2003
A good death is characterized by physical comfort, social support, acceptance, and appropriate medical care, and it should minimize psychological distress for dying and their families. 6 Long, 2003 A gradual process that allows time for personal growth and acceptance, spiritual exploration, life review, and the opportunity to mend relationships and say good-byes. The degree to which a person's preferences for dying and the moment of death agree with observations of how the person actually died as reported by others.
Wenger & Resenfeld, 2001)
A death that is free from avoidable distress and suffering for patients, families, and their caregivers; in general accord with the patients' and families' wishes; and reasonably consistent with clinical, cultural, and ethical standards.
12
Mak & Clinton, 1999 Good death as "one in which patients' wants and needs are met".
13 Kearl, 1996 Dying well involves both the individual's own strategies and the social recognition of their attempts. Deaths become good "when they serve not only the needs of the dying but also those of the survivors and of the broader social orders as well". In order for the social and psychological aspects of death awareness and acceptance to take place, the dying person's suffering should be reduced and they must be relieved of pain (Weisman, 1978) . As the hospice movement developed from its inception in 1967 (Stoddard S, 1978) , the good death philosophy has expanded to incorporate notions of control on the part of the person who is dying (Logue, 1994) . Alzheimer's disease (AD) patients, who will require a special approach to care both from psychosocial and medical aspects in all stages of their dementia for the indefinite future.
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In an absence of curative strategies, palliative care that is attempting to improve symptoms of these AD patients and treat intercurrent medical condition is appropriate.
However, aggressive care and palliative care are not mutually exclusive and both can be In conclusion, QODD should be combined of psychological, medical and social support as external role and their patient's decision-making as internal role in palliative care research. These roles complement each other. Given this knowledge, future research would be able to refer on measuring QODD for non-cancer patients.
